# OnCo record nct06769698 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06769698/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06769698", "NCT06769698" ;
  schema:name "A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous "@en ;
  schema:description "A phase 2 trial of Cemiplimab, Fianlimab in head and neck squamous cell carcinoma, run by Regeneron Pharmaceuticals, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06769698/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06769698> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2026-04-14" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/cemiplimab/>, <https://onco.cc/drugs/fianlimab/> ;
  onco:companies <https://onco.cc/companies/regeneron/> .